Approval Year
Substance Class |
Polymer
Created
by
admin
on
Edited
Sat Dec 16 03:42:45 UTC 2023
by
admin
on
Sat Dec 16 03:42:45 UTC 2023
|
Record UNII |
O03S90U1F2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
468414
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
||
|
FDA ORPHAN DRUG |
22687
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
||
|
WHO-ATC |
A11HA08
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VEDROP (AUTHORIZED: CHOLESTASIS)
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
||
|
WHO-VATC |
QA11HA08
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1706
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108106
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
C67044
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108812
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
SUB31955
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
TOCOFERSOLAN
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
100000124318
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
C014225
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
9002-96-4
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
O03S90U1F2
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
DB11635
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
159151
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID1048623
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
O03S90U1F2
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY | |||
|
4280
Created by
admin on Sat Dec 16 03:42:45 UTC 2023 , Edited by admin on Sat Dec 16 03:42:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
TPGS enhances vitamin D absorbtion in chronic cholestatic liver disease of infancy and childhood (17). In 1999, the increased absorption of an anti-HIV protease inhibitor was suggested as a consequence of the drug’s solubility and permeability increase.
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
HYDROPHILLIC-LIPOPHILLIC BALANCE (HLB) | CHEMICAL |
|
|
|||
VISCOSITY | PHYSICAL |
|
||||
MOL_WEIGHT:NUMBER AVERAGE | CHEMICAL |
|
|
|||